Sitagliptin Tablet
Product Images NDC 70710-1901

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 70710-1901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C489d9fa C7f0 473f 9f7b 77086e137e8f 01)

Chemical structure of sitagliptin, showing its molecular arrangement including fluorine and trifluoromethyl groups, consistent with the active ingredient sitagliptin used in oral tablet form.*

FDA Label Image

Image (C489d9fa C7f0 473f 9f7b 77086e137e8f 02)

A line graph depicting the Least Squares (LS) mean change from baseline over a 24-week period in different treatment groups. The x-axis represents weeks (0, 6, 12, 18, 24) and the y-axis shows LS mean change from baseline. Treatment groups include placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, Sitagliptin 50 mg twice daily combined with Metformin 500 mg twice daily, and Sitagliptin 50 mg twice daily combined with Metformin 1000 mg twice daily.*

FDA Label Image

Image (C489d9fa C7f0 473f 9f7b 77086e137e8f 03)

A line graph depicting the least squares mean change from baseline over a 52-week period. The x-axis represents the week number from 0 to 52, and the y-axis shows the LS mean change from baseline ranging from 0.0 to -1.5. Two lines with distinct markers illustrate trends over time, both showing a decrease in LS mean change until around week 30 followed by a gradual increase towards week 52.*

FDA Label Image

25 mg Label (C489d9fa C7f0 473f 9f7b 77086e137e8f 04)

Sitagliptin Tablets 25 mg oral film-coated tablets label by Zydus Pharmaceuticals (USA) Inc. The label includes the NDC 70710-1899-9 and states a package size of 90 tablets for prescription use only. It provides storage instructions, child-resistant packaging notice, and directs users to the medication guide. Manufacturer information lists Zydus Lifesciences Ltd., Ahmedabad, India.*

FDA Label Image

50 mg Label (C489d9fa C7f0 473f 9f7b 77086e137e8f 05)

Sitagliptin Tablets 50 mg label from Zydus Pharmaceuticals (USA) Inc. The label includes the NDC 70710-1900-9 and shows the dosage strength prominently in blue. It indicates the package contains 90 film-coated tablets. Storage instructions and contact information for medication guides are provided. The label also contains a barcode and manufacturer details for Zydus Lifesciences Ltd., India, with distribution by Zydus Pharmaceuticals in Pennington, NJ.*

FDA Label Image

100 mg Label (C489d9fa C7f0 473f 9f7b 77086e137e8f 06)

Sitagliptin 100 mg tablets packaging label by Zydus Pharmaceuticals (USA) Inc. The label indicates 90 oral tablets with prescription use only. It includes manufacturer details, dosing instructions referencing prescribing information, storage conditions, child-resistant packaging warning, and a prompt to dispense the enclosed Medication Guide. The label features the Zydus logo and an NDC number 70710-1901-9.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.